Auditory Brainstem Response as a Diagnostic Tool in Schizophrenia and Bipolar Disorder

NCT01629355 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 66

Last updated 2015-09-01

No results posted yet for this study

Summary

The purpose of this study is to study the predictive value of SensoDetect-BERA as a diagnostic tool in clinical practice for schizophrenia and bipolar disorder.

Conditions

Sponsors & Collaborators

  • SensoDetect

    collaborator INDUSTRY
  • University Hospital of North Norway

    lead OTHER

Principal Investigators

  • Rolf Wynn, M.D., Ph.D. · University Hospital of North Norway

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2015-05-31
Completion
2015-08-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01629355 on ClinicalTrials.gov